Journals / ANKEM Dergisi / 2007 / Cilt: 21 - Sayı: 3

Antifungal susceptibility of Candida albicans isolates recovered from blood cultures of intensive care unit patients

Yoğun bakım ünitesinde yatan hastaların kan kültürlerinden izole edilen Candida albicans suşlarında antifungallere duyarlılık

Pages
146–149
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, resistance is uncommon in C.albicans strains isolated from blood cultures of intensive care unit patients in our hospital.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The in vitro activities of amphotericin B, fluconazole, itraconazole and flucytosine were determined against 68 Candida albicans isolates recovered from blood cultures of intensive care unit patients.
📊
Key Findings & Data:All isolates were found to be susceptible to am-photericin B, fluconazole and flucytosine.
💡
Conclusion & Impact:In conclusion, resistance is uncommon in C.albicans strains isolated from blood cultures of intensive care unit patients in our hospital.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Mikolojik tiplendirme teknikleri · Candida albicans · İlaç direnci

Abstract

The in vitro activities of amphotericin B, fluconazole, itraconazole and flucytosine were determined against 68 Candida albicans isolates recovered from blood cultures of intensive care unit patients. All isolates were found to be susceptible to am-photericin B, fluconazole and flucytosine. Dose-dependent susceptibility to itraconazole was observed in only two C.albicans isolates. In conclusion, resistance is uncommon in C.albicans strains isolated from blood cultures of intensive care unit patients in our hospital.

Özet

Yoğun bakım ünitesinde yatan hastaların kan kültürlerinden izole edilen 68 Candida albicans izolatının, amfoterisin B, flukonazol, itrakonazol ve flusitozin duyarlılıkları belirlenmiştir. Tüm izolatlar amfoterisin B, flukonazol ve flusitozine duyarlı bulunmuştur. İki C.albicans izolatının itrakonazole doza bağımlı duyarlı olduğu gözlenmiştir. Sonuç olarak hastanemiz yoğun bakımında yatan hastaların kan kültürlerinden izole edilen C.albicans suşlarında antifungal direnci bulunmamaktadır.

🔖

Cite This Article

YENİŞEHİRLİ, G., BULUT, Y., GÜNDAY, E. (2007). Antifungal susceptibility of Candida albicans isolates recovered from blood cultures of intensive care unit patients. ANKEM Dergisi, Cilt: 21 - Sayı: 3, 146–149. https://ajindex.com/articles/199540

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S: The epidemiology of hematogenous candidiasis caused by different Candida species, Clin Infect Dis 1997;24(6):1122-8
  2. Aquino VR, Lunardi LW, Goldani LZ, Barth AL: Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil, Braz J Infect Dis 2005;9(5):411-8
  3. Arıkan S, Arslan Ş, Hasçelik G, Günalp A: Hacettepe Üniversitesi hastanesinde kan kültürlerinden izole edilen mayaların antifungal ajanlara in vitro duyarlılıkları, Mikrobiyol Bült 2001;35(3):433-41
  4. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M: Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland, J Clin Microbiol 2002;40(9):3489-92
  5. Bakir M, Cerikcioglu N, Barton R, Yagci A: Epidemiology of candidemia in a Turkish tertiary care hospital, APMIS 2006;114(9):601-10
  6. Basetti M, Righi E, Costa A et al: Epidemiological trends in nosocomial candidemia in intensive care, BMC Infect Dis 2006;6:21
  7. Colombo AL, Nucci M, Park BJ et al: Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers, J Clin Microbiol 2006;44(8):2816-23
  8. Colombo AL, Perfect J, DiNubile M et al: Global distribution and. outcomes for Candida species causing invasive candidiasis, results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis, Eur J Clin Microbiol Infect Dis 2003;22(8):470-4
  9. Cuenca-Estrella M, Rodriguez D, Almirante B et al: In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003, J Antimicrob Chemother 2005;55(2):194-9
  10. Hajjeh RA, Sof air AN, Harrison LH et al: Incidence of blood stream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population based active surveillance program, J Clin Microbiol 2004;42(4):1519-27
  11. Jarvis WR: Epidemiology of nosocomial fungal infections, with emphasis on Candida species, Clin Infect Dis 1995;20(6):1526-30
  12. Kauffman CA, Frame PT: Bone marrow toxicity associated with 5-fluorocytosine therapy, Antimicrob Agent Chemother 1977;ll(2):244-7
  13. Kibbler CC, Seaton S, Barnes RA et al: Management and outcome of bloodstream infections due to Candida species in England an